These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350 [TBL] [Abstract][Full Text] [Related]
65. [The Tuaregs addiction to tea, to smokeless tobacco and to milk: ethnological and clinical approach]. Hureiki J; Laqueille X Encephale; 2003; 29(1):42-8. PubMed ID: 12640326 [TBL] [Abstract][Full Text] [Related]
66. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms. Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897 [TBL] [Abstract][Full Text] [Related]
67. Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. Cottler LB; Leung KS; Abdallah AB Addiction; 2009 Oct; 104(10):1679-90. PubMed ID: 19681802 [TBL] [Abstract][Full Text] [Related]
68. [Fluoxetine dependence and tolerance. Apropos of a case]. Menecier P; Menecier-Ossia L; Bern P Encephale; 1997; 23(5):400-1. PubMed ID: 9453934 [TBL] [Abstract][Full Text] [Related]
69. Aspects of tolerance to and dependence on cannabis. Wikler A Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472 [TBL] [Abstract][Full Text] [Related]
70. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]. Ampélas JF; Wattiaux MJ; Van Amerongen AP Encephale; 2001; 27(6):588-99. PubMed ID: 11865567 [TBL] [Abstract][Full Text] [Related]
71. The behavioral profile of spice and synthetic cannabinoids in humans. Müller HH; Kornhuber J; Sperling W Brain Res Bull; 2016 Sep; 126(Pt 1):3-7. PubMed ID: 26548494 [TBL] [Abstract][Full Text] [Related]
72. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper. Epstein DH; Preston KL Am J Addict; 2015 Jun; 24(4):323-8. PubMed ID: 25846329 [TBL] [Abstract][Full Text] [Related]
73. Proposed changes in DSM-III substance use disorders: description and rationale. Rounsaville BJ; Spitzer RL; Williams JB Am J Psychiatry; 1986 Apr; 143(4):463-8. PubMed ID: 3953889 [TBL] [Abstract][Full Text] [Related]
74. Dependence on benzodiazepines. Lader M J Clin Psychiatry; 1983 Apr; 44(4):121-7. PubMed ID: 6131885 [TBL] [Abstract][Full Text] [Related]
75. The time course and significance of cannabis withdrawal. Budney AJ; Moore BA; Vandrey RG; Hughes JR J Abnorm Psychol; 2003 Aug; 112(3):393-402. PubMed ID: 12943018 [TBL] [Abstract][Full Text] [Related]
76. [Case of phenacetin drug dependence]. Denisenko GT; Pishchalenko AN Vrach Delo; 1988 Jul; (7):75-6. PubMed ID: 3188476 [No Abstract] [Full Text] [Related]